Virax Biolabs Group Limited Ordinary Shares Share Price
NASDAQ: VRAXHealthcare
Live Virax Biolabs Group Limited Ordinary Shares Share Price Chart
O H L
Virax Biolabs Group Limited Ordinary Shares Performance Overview
Days Range
▼
$2.13Low
$2.13High
Markets Today
| Previous Close | $2.24 |
|---|---|
| Open | $2.13 |
| Volume | 19,197 |
| Day's Range | $2.13 - $2.13 |
| 52W Range | $2.04 - $21.75 |
| Market Cap | $1.79 M |
Historical Performance
| 1M Returns | -14.06 |
|---|---|
| 3M Returns | -29.71 |
| 6M Returns | -49.43 |
| 1Y Returns | -85.72 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Virax Biolabs Group Limited Ordinary Shares Fundamentals
| Market Cap | $1.79 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $12.42 K |
| ROE TTM | -0.76 |
| EPS TTM | $-23.09 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.17 |
| EBITDA | $-6.04 M |
| Profit Margin | -40439.10 |
| Market Cap | $1.79 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $12.42 K |
| ROE TTM | -0.76 |
| EPS TTM | $-23.09 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.17 |
| EBITDA | $-6.04 M |
| Profit Margin | -40439.10 |
Virax Biolabs Group Limited Ordinary Shares Profit & Loss
Quarterly
| Total Revenue + |
| Gross Profit + |
| Operating Income |
| EBITDA |
| Interest Expense |
| Depreciation |
| Income Before Tax |
| Income Tax Expense |
| Net Income + |
| Net Profit Margin |
Virax Biolabs Group Limited Ordinary Shares Financials Balance Sheet In USD
Quarterly
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Share Capital | $1.56 K | $2.57 K | $4.34 K | $14.48 K |
| Reserve & Surplus | -$11.80 M | -$18.53 M | -$24.48 M | -$29.92 M |
| Non-Current Liabilities | $0 | $176.34 K | $291.54 K | $304.81 K |
| Current Liabilities | $908.40 K | $168.85 K | $673.21 K | $685.02 K |
| Total Liabilities | $908.40 K | $345.19 K | $964.75 K | $989.83 K |
| Fixed Assets | $178.40 K | $897.63 K | $1.23 M | $1.17 M |
| Current Assets | $9.63 M | $4.38 M | $4.89 M | $6.83 M |
| Total Assets | $9.81 M | $5.48 M | $6.43 M | $8.32 M |
Virax Biolabs Group Limited Ordinary Shares Cash Flow
Quarterly
| Net Income |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Change in Cash |
Virax Biolabs Group Limited Ordinary Shares Return Calculator
The Virax Biolabs Group Limited Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Virax Biolabs Group Limited Ordinary Shares
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
Popular Stocks
FAQs
What is the share price of Virax Biolabs Group Limited Ordinary Shares today?
Virax Biolabs Group Limited Ordinary Shares (VRAX) share price as of October 3, 2026 is $2.10. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Virax Biolabs Group Limited Ordinary Shares?
Yes, Indian Investors can invest in the Virax Biolabs Group Limited Ordinary Shares (VRAX) Share by opening an international trading account with Angel One.
How can I purchase Virax Biolabs Group Limited Ordinary Shares shares in India?
Purchasing Virax Biolabs Group Limited Ordinary Shares (VRAX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Virax Biolabs Group Limited Ordinary Shares (VRAX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Virax Biolabs Group Limited Ordinary Shares?
Yes, you can purchase fractional shares of Virax Biolabs Group Limited Ordinary Shares (VRAX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Virax Biolabs Group Limited Ordinary Shares?
The market capitalization of Virax Biolabs Group Limited Ordinary Shares on October 3, 2026, is $1.79 M.
In which sector Virax Biolabs Group Limited Ordinary Shares belongs?
Virax Biolabs Group Limited Ordinary Shares operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Virax Biolabs Group Limited Ordinary Shares stocks?
In order to invest in Virax Biolabs Group Limited Ordinary Shares (VRAX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
